News
07-12-2025, 09:38 AM
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.
More... (https://www.news-medical.net/news/20250712/ALKBH3-regulates-glycolysis-and-doxorubicin-resistance-in-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20250712/ALKBH3-regulates-glycolysis-and-doxorubicin-resistance-in-triple-negative-breast-cancer.aspx)